Does cholinesterase inhibitor use significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer 's disease from dementia with Lewy bodies?
Use of ChEi does not significantly influence the ability of 123I-FP-CIT imaging to distinguish AD from DLB.
A164S is the first mutation in APOA1 to be described that predicts an increased risk of IHD, MI and total mortality without low HDL cholesterol levels.